AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Other Oncology medicines by Year
Other Oncology medicines — Worldwide product sales ($M) ($M)
AstraZeneca Other Oncology medicines: $425M in FY2025, up 1.4% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Other Oncology | 425 | (8) | (8) | 9 | (52) | 280 | (6) | (4) | 19 | (17) | (19) | 117 | (6) | (7)”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Oncology medicines — Worldwide product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 425 | +1.4% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 419 | +87.1% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 224 | +409.1% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 44 | -12.0% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 50 | -73.8% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 191 | +103.2% | Form 6-K FY2020Q4 Earnings Release ↗ |
| FY2019 | Dec 31, 2019 | 94 | -18.3% | Form 20-F (filed 2020-03-03) ↗ |
| FY2018 | Dec 31, 2018 | 115 | +0.9% | Form 20-F (filed 2019-03-05) ↗ |
| FY2017 | Dec 31, 2017 | 114 | +9.6% | Form 20-F (filed 2019-03-05) ↗ |
| FY2016 | Dec 31, 2016 | 104 | – | Form 20-F (filed 2019-03-05) ↗ |
Breakdown
What makes up other Oncology medicines
- Other Oncology medicines — Worldwide YoY actual (%)-8.0% · FY2025
- Other Oncology medicines — Worldwide YoY CER (%)-8.0% · FY2025
- Other Oncology medicines — US product sales ($M)9 · FY2025
- Other Oncology medicines — Emerging Markets product sales ($M)280 · FY2025
- Other Oncology medicines — Europe product sales ($M)19 · FY2025
- Other Oncology medicines — Established RoW product sales ($M)117 · FY2025
Cite this data
StockData. (2026). AstraZeneca Other Oncology medicines ($M), annual FY2016–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-oncology-world
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.